Immunohistochemical investigation of the correlation between LIM kinase 1 expression and development and progression of human ovarian carcinoma

Journal of International Medical Research

Volumn 40, Issue 3, 2012, Pages 1067-1073

  Zhang, W ^a   Gan, N ^a   Zhou, Jianwei ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

LIM kinase 1; Primary Ovarian Carcinoma; Tumour cell invasion; Tumour cell progression

Indexed keywords

LIM KINASE 1;

ARTICLE; BENIGN TUMOR; BORDERLINE TUMOR; CANCER GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVESTIGATIVE PROCEDURES; LIMK1 GENE; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CARCINOMA; PRIMARY OVARIAN EPITHELIAL TUMOR; PRIMARY TUMOR; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCORING SYSTEM; TUMOR DIFFERENTIATION;

EID: 84863089421     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000325     Document Type: Article

References (24)

1. Yang L, Klint A, Lambe M, et al: Predictors of ovarian cancer survival: a population-based prospective study in Sweden. Int J Cancer 2008; 123: 672-679.
2. Kim PS, Djazayeri S, Zeineldin R: Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer. Gynecol Oncol 2011; 120: 393-403.
3. Chung HH, Hwang SY, Jung KW, et al: Ovarian cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer 2007; 17: 595-600.
4. Perlman S, Ben-Arie A: Neoadjuvant chemotherapy for advanced ovarian cancer. Harefuah 2010; 149: 377-381, 402 [in Hebrew, English abstract].
5. Chi DS, Eisenhauer EL, Zivanovic O, et al: Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 2009; 114: 26-31.
6. Lutz AM, Willmann JK, Drescher CW, et al: Early diagnosis of ovarian carcinoma: is a solution in sight? Radiology 2011; 259: 329-345.
7. Gao L, Cheng HY, Dong L, et al: The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis. J Int Med Res 2011; 39: 1645-1660.
8. Balbi G, Monteverde A, Landino I, et al: Cytoreductive surgery and ovarian carcinoma. Acta Biomed 2009; 80: 230-233.
9. Monk BJ, Coleman RL: Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds. Int J Gynecol Cancer 2009; 19(suppl 2): S63-S67.
10. Roomi MW, Ivanov V, Kalinovsky T, et al: Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract. J Obstet Gynaecol Res 2006; 32: 148-154.
11. Lutz V, Reuning U, Krüger A, et al: High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice. Biol Chem 2001; 382: 789-798.
12. Haller H, Mamula O, Krasevic M, et al: Frequency and distribution of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer 2011; 21: 245-250.
13. Bernard O: LIM kinases, regulators of actin dynamics. Int J Biochem Cell Biol 2007; 39: 1071-1076.
14. Montani L, Gerrits B, Gehrig P, et al: Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system. J Biol Chem 2009; 284: 10793-10807.
15. Rösel D, Brábek J, Tolde O, et al: Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 2008; 6: 1410-1420.
16. Arber S, Barbayannis FA, Hanser H, et al: Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998; 393: 805-809.
17. McConnell BV, Koto K, Gutierrez-Hartmann A: Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression. Mol Cancer 2011; 10: 75.
18. Scott RW, Hooper S, Crighton D, et al: LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol 2010; 191: 169-185.
19. Tavassoéli FA, Devilee P (eds): WHO Classification: Pathology and Genetics of Tumours of the Breast and Female Genital Organs, 1st edn. Lyon: IARC Press, 2003; p 432.
20. Shackelford RE, Bui MM, Coppola D, et al: Overexpression of nicotinamide phosphoribosyl-transferase in ovarian cancers. Int J Clin Exp Pathol 2010; 3: 522-527.
21. Linghu H, Tsuda M, Makino Y, et al: Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene 2006; 25: 3547-3556.
22. Yamaguchi H, Condeelis J: Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007; 1773: 642-652.
23. Breitsprecher D, Koestler SA, Chizhov I, et al: Cofilin cooperates with fascin to disassemble filopodial actin filaments. J Cell Sci 2011; 124: 3305-3318.
24. Kidera Y, Tsubaki M, Yamazoe Y, et al: Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statininduced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway. J Exp Clin Cancer Res 2010; 29: 127.